© 2020 MJH Life Sciences and OncLive. All rights reserved.
July 03, 2020
Richard D. Kim, MD, discusses the efficacy of and next steps for a phase 1/1b study with regorafenib and nivolumab in patients with mismatch repair proficient advanced refractory colorectal cancer.
December 18, 2019
Richard Kim, MD, discusses the use of immunotherapy in colorectal cancer.
December 13, 2019
Richard Kim, MD, discusses how molecular profiling can be used to optimize outcomes in patients with metastatic colorectal cancer.
November 16, 2019
Richard Kim, MD, discusses treatment options for BRAF-mutant colon cancer.